Canaccord Genuity Reiterates a Buy Rating on Intuitive Surgical

By Austin Angelo

Canaccord Genuity analyst Jason Mills reiterated a Buy rating on Intuitive Surgical (NASDAQ: ISRG) today and set a price target of $870. The company’s shares opened today at $800.

According to, Mills is a 4-star analyst with an average return of 5.4% and a 61.5% success rate. Mills covers the Healthcare sector, focusing on stocks such as Integer Holdings Corporation, Tactile Systems Technology, and Trivascular Technologies.

Currently, the analyst consensus on Intuitive Surgical is Moderate Buy and the average price target is $813.70, representing a 1.7% upside.

In a report issued on April 17, Barclays also maintained a Buy rating on the stock with a $870 price target.

Intuitive Surgical’s market cap is currently $29.67B and has a P/E ratio of 38.31. The company has a book value ratio of 5.0992.

Based on the recent corporate insider activity of 65 insiders, corporate insider sentiment is negative on the stock. Last month, Lonnie Smith, a Director at ISRG sold 35 shares for a total of $25,767.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.